Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 2
1999 2
2000 1
2001 4
2002 1
2003 2
2004 2
2005 5
2006 4
2007 9
2008 4
2009 4
2010 6
2011 8
2012 3
2013 2
2014 1
2015 5
2016 2
2017 5
2018 3
2019 2
2020 4
2021 7
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Results by year
Filters applied: . Clear all
Page 1
HLA-G: An Immune Checkpoint Molecule.
Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, Moreau P, LeMaoult J. Carosella ED, et al. Among authors: lemaoult j. Adv Immunol. 2015;127:33-144. doi: 10.1016/ Epub 2015 May 27. Adv Immunol. 2015. PMID: 26073983 Review.
Editorial: The Biological and Clinical Aspects of HLA-G.
LeMaoult J, Yan WH. LeMaoult J, et al. Front Immunol. 2021 Feb 19;12:649344. doi: 10.3389/fimmu.2021.649344. eCollection 2021. Front Immunol. 2021. PMID: 33679813 Free PMC article. No abstract available.
Role of the HLA-G immune checkpoint molecule in pregnancy.
Rouas-Freiss N, Moreau P, LeMaoult J, Papp B, Tronik-Le Roux D, Carosella ED. Rouas-Freiss N, et al. Among authors: lemaoult j. Hum Immunol. 2021 May;82(5):353-361. doi: 10.1016/j.humimm.2021.01.003. Epub 2021 Mar 19. Hum Immunol. 2021. PMID: 33745758 Review.
The dual role of HLA-G in cancer.
Rouas-Freiss N, Moreau P, LeMaoult J, Carosella ED. Rouas-Freiss N, et al. Among authors: lemaoult j. J Immunol Res. 2014;2014:359748. doi: 10.1155/2014/359748. Epub 2014 Mar 31. J Immunol Res. 2014. PMID: 24800261 Free PMC article. Review.
The role of HLA-G in immunity and hematopoiesis.
Carosella ED, Gregori S, Rouas-Freiss N, LeMaoult J, Menier C, Favier B. Carosella ED, et al. Among authors: lemaoult j. Cell Mol Life Sci. 2011 Feb;68(3):353-68. doi: 10.1007/s00018-010-0579-0. Epub 2010 Nov 30. Cell Mol Life Sci. 2011. PMID: 21116680 Review.
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.
Anna F, Bole-Richard E, LeMaoult J, Escande M, Lecomte M, Certoux JM, Souque P, Garnache F, Adotevi O, Langlade-Demoyen P, Loustau M, Caumartin J. Anna F, et al. Among authors: lemaoult j. J Immunother Cancer. 2021 Mar;9(3):e001998. doi: 10.1136/jitc-2020-001998. J Immunother Cancer. 2021. PMID: 33737343 Free PMC article.
The immunosuppressive molecule HLA-G and its clinical implications.
González A, Rebmann V, LeMaoult J, Horn PA, Carosella ED, Alegre E. González A, et al. Among authors: lemaoult j. Crit Rev Clin Lab Sci. 2012 May-Jun;49(3):63-84. doi: 10.3109/10408363.2012.677947. Epub 2012 Apr 26. Crit Rev Clin Lab Sci. 2012. PMID: 22537084 Review.
Research on HLA-G: an update.
Favier B, LeMaoult J, Rouas-Freiss N, Moreau P, Menier C, Carosella ED. Favier B, et al. Among authors: lemaoult j. Tissue Antigens. 2007 Mar;69(3):207-11. doi: 10.1111/j.1399-0039.2006.00757.x. Tissue Antigens. 2007. PMID: 17493143 Review.
HLA-G: from biology to clinical benefits.
Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. Carosella ED, et al. Among authors: lemaoult j. Trends Immunol. 2008 Mar;29(3):125-32. doi: 10.1016/ Epub 2008 Feb 4. Trends Immunol. 2008. PMID: 18249584 Review.
84 results